Literature DB >> 7729868

Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes.

S M Muth1, J W Murphy.   

Abstract

Immunizing CBA/J mice with intact Cryptococcus neoformans cells or with a cryptococcal culture filtrate antigen (CneF) induces an anticryptococcal delayed-type hypersensitivity response. Recently, it has been shown that two phenotypically different T-cell populations are responsible for delayed-type hypersensitivity reactivity in mice immunized with intact cryptococcal cells, whereas only one of those populations is present in mice immunized with soluble cryptococcal antigens in complete Freund's adjuvant (CFA). The purpose of this study was to determine if differences occur with regard to direct anticryptococcal activity between T-lymphocyte-enriched populations from mice immunized with intact viable or dead cryptococcal cells and similar cell populations from mice immunized with the soluble cryptococcal culture filtrate antigen, CneF, emulsified in CFA. The percentage of lymphocytes which form conjugates with C. neoformans and the percentage of cryptococcal growth inhibition in vitro are greater with T-lymphocyte-enriched populations from mice sublethally infected with C. neoformans or from mice immunized with intact heat-killed cryptococcal cells in the presence or absence of CFA than with lymphocyte populations from mice immunized with CneF-CFA. Enhanced anticryptococcal activity of T lymphocytes could be induced by immunizing mice with heat-killed C. neoformans cells of serotype A, B, C, or D as well as by immunizing with a similar preparation of an acapsular C. neoformans mutant but not by immunizing with CFA emulsified with CneF prepared from any one of the C. neoformans isolates. These data indicate that the soluble cryptococcal culture filtrate antigens do not induce the same array of functional T lymphocytes as whole cryptococcal cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729868      PMCID: PMC173204          DOI: 10.1128/iai.63.5.1645-1651.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

2.  Murine natural killer cells are fungicidal to Cryptococcus neoformans.

Authors:  M R Hidore; N Nabavi; F Sonleitner; J W Murphy
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

3.  Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection.

Authors:  L K Cauley; J W Murphy
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

4.  CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans.

Authors:  C H Mody; R Paine; C Jackson; G H Chen; G B Toews
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

5.  Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice.

Authors:  S M Muth; J W Murphy
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

6.  Host defense in cryptococcosis. III. Protection of nude mice by thymus transplantation.

Authors:  J R Graybill; L Mitchell; D J Drutz
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

7.  T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice.

Authors:  G B Huffnagle; J L Yates; M F Lipscomb
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

8.  Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.

Authors:  K L Buchanan; J W Murphy
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

9.  Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells.

Authors:  G B Huffnagle; J L Yates; M F Lipscomb
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

10.  Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells.

Authors:  J O Hill; A G Harmsen
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  6 in total

1.  Requirement for CD4(+) T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice.

Authors:  K L Buchanan; H A Doyle
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans.

Authors:  J W Murphy; F Schafer; A Casadevall; A Adesina
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans.

Authors:  Kasie L Nichols; Sean K Bauman; Fredda B Schafer; Juneann W Murphy
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response.

Authors:  T McGaha; J W Murphy
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  Identification and cloning of a cryptococcal deacetylase that produces protective immune responses.

Authors:  Carmelo Biondo; Concetta Beninati; Demetrio Delfino; Marco Oggioni; Giuseppe Mancuso; Angelina Midiri; Mauro Bombaci; Giuseppe Tomaselli; Giuseppe Teti
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice.

Authors:  S M Muth; J W Murphy
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.